{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P55072",
      "entity_text" : "VCP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5978",
      "entity_text" : "Vincristine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "One study using animal models suggested a neuroprotective effect with erythropoietin (EPO).3 EPO, a well recognized hematopoietic factor, was noted to have numerous functions outside of the bone marrow and that recombinant human EPO (r-Hu-EPO) can cross the blood-brain barrier.3 Interestingly, there is also evidence that glutamine may improve sensory function in vincristine induced neuropathy when studied in the pediatric populations.4 Vincristine induced VCP is fortunately reversible.",
  "reading_complete" : "2020-08-03T14:20:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:19:27Z",
  "trigger" : "induced",
  "evidence" : [ "Vincristine-induced VCP" ],
  "pmc_id" : "6389462",
  "score" : 0
}